Indonesia In Vitro Diagnostics (IVD) Market Research Report: Forecast (2024-2030)

Market Definition

In Vitro Diagnostics (IVD) describes the procedures, tests, and examinations performed on samples taken from various forms of the body fluids, such as blood, urine, tissues, and so on, outside the living organism for information on the condition of a person's health or medical situation.

Market Insights & Analysis: Indonesia in Vitro Diagnostics (IVD) Market (2024-30):

The Indonesia In Vitro Diagnostics (IVD) Market is estimated to grow at a CAGR of about 9.35% during the forecast period, i.e., 2024-30. The factors attributing to the surge in IVD are the rising incidence of chronic ailments, growing healthcare expenditure, the increasing elderly population, and budding awareness programs for early disease detection.  In recent years, the lifestyle of the individuals residing in Indonesia has drastically changed and they have been increasingly consuming unhealthy food. Also, based on the statistics by the Ministry of Health, more than 95% of individuals consume unhealthy food, including packaged & junk food.

Along with this, consumers have a hectic schedule, owing to which they spend fewer hours on physical exercise. As per the survey, only 20% of the individuals in Indonesia regularly engage themselves in any physical workout. Thus, less physical activity & inadequate eating habits result in higher occurrences of diseases, like obesity & overweight. More than 35.4% of individuals, i.e., around 68 million individuals are obese in Indonesia as per the Official Health Authorities. These diseases can cause harm to another vital organs of the body, therefore, the patients need to undergo immediate disease detection & prevention, supporting the In Virto Diagnostics (IVD) Market.

Additionally, the geriatric population in Indonesia is increasing due to low mortality rates. In accordance with the research by the World Bank, the death rate in the country was around 0.94%. These elderly populations are at higher risk of contracting severe health problems. As a result, they undergo regular diagnostics tests, enlarging the Indonesia In Vitro Diagnostics Market size. Also, the elderly population of the country will grow from 10% to 18% in 2040, as per the National Institutes of Health (NIH). Thus, IVD demand for quick diagnosis, monitoring, and treatment of health problems in the elderly population will increase in the forthcoming years.

Moreover, the top companies in the market are actively laying awareness programs, like the Pink Ribbon Program, to educate individuals about health problems and their detection & treatment. These campaigns would help the inhabitants focus on their health & undergo regular health checkups, uplifting the demand for In Vitro Diagnostics during 2024-2030.

Indonesia In Vitro Diagnostics (IVD) Market Driver:

Increasing Healthcare Expenditure – In recent years, healthcare expenditure in Indonesia has increased drastically, owing to which there has been development of adequate healthcare infrastructure and greater adoption of advanced diagnostics products. During 2019-2023, Indonesia recorded economic growth and a surging middle class population. With higher disposable incomes, more inhabitants are willing to spend on healthcare services, including private healthcare. Based on the data published by the World Bank, as of 2023, almost 2% of the Indonesian population spends at least 10% of their total income on their health.

Along with this, the Indonesian health authorities are substantially investing in the healthcare sector to improve access and quality of care. The governing bodies are launching initiatives and providing subsidies & grants to expand healthcare infrastructure & enhance healthcare services. These substantial fund allocations are encouraging the hospitals to adopt next-generation diagnostics tools, including In Vitro, and provide high-quality treatment to the inhabitants, driving the Indonesia In Vitro Diagnostics Market.   

Indonesia In Vitro Diagnostics (IVD) Market Challenge:

Lack of Skilled Laboratory Professionals – In recent years, Indonesia witnessed the migration of several skilled healthcare professionals, including lab technicians due to better work opportunities in neighboring & North American nations. This has caused a lack of workforce in the healthcare sector. The ratio of medical doctors to the overall Indonesian population stands at 1:1,333. This shortage of skilled laboratory professionals makes it challenging for the laboratories & hospitals to run these services. As a result, several healthcare facilities in Indonesia provide conventional diagnostics tests rather than in vitro diagnostics, slowing down the market growth.

Additionally, the role of specialized professionals is critical within the healthcare setting owing to the constant technological developments and the increased need for personalized medicine. However, the dearth of skilled workforce adversely affects the effectiveness and quality of the in vitro diagnostic services in Indonesia. This in turn causes late diagnosis and poor care quality, causing worry among the end-users. Consequently, IVD acceptance and demand have been affected negatively, further restraining the Indonesia In Vitro Diagnostics (IVD) Market growth.

Indonesia In Vitro Diagnostics (IVD) Market (2024-30): Segmentation Analysis

Indonesia In Vitro Diagnostics (IVD) Market study by MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the country level. As per the analysis, the market has been further classified as:

Based on Application

• Infectious Diseases
• Oncology
• Cardiology
• Nephrology
• Diabetes
• Drug Monitoring & Testing
• Others

The Oncology segment of the Indonesia In Vitro Diagnostics (IVD) Market is anticipated to grow with a significant market share over the forecast period. The occurrence of several cancer types has promoted the demand for In Vitro Diagnostics (IVD), such as cobas® EGFR Mutation Test for lung cancer detection and monitoring in Indonesia. As per the WHO Global Cancer Observatory, there were about 409,000 new cases of cancer reported in Indonesia in 2022. In the years ahead, the number of cases is forecasted to reach 640,000 by 2045. Hence, this market segment is expected to evolve through the growth phase.

In addition, government & non-governmental initiatives have been successful in helping Indonesians understand early diagnosis and better survival of cancer patients. This has led people to go for IVD tests that provide information about a patient's health status, including their risk or predisposition to develop a certain cancer. The various risk factors such as smoking, old age, alcohol consumption, etc. have further driven the segmental market growth.

Based on the End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Homecare Settings
• Others

The Hospitals & Clinics held a noteworthy share in the Indonesia IVD Market. The hospitals and clinics are major medical facilities that provide care to individuals suffering from different conditions. Indonesia is emerging as a popular medical tourism hotspot for European & North American patients due to the availability of inexpensive treatment plans in Indonesia. Along with this, Indonesian hospitals & clinics offer a broad spectrum of medical services, including general health check-ups and specialized treatments. The wide diagnostics provided by the healthcare facilities fulfill the needs of a broad range of patients & make them a preferable choice for customers.

Additionally, several healthcare providers are now offering tailored services to meet the specific needs and preferences of foreign patients. They are actively integrating the latest medical technology & using new and highly advanced medical equipment for both diagnostics & treatments, consequently, amplifying the Indonesia IVD Market.

Indonesia In Vitro Diagnostics (IVD) Industry Recent Development:

• 2023: Fapon, signed a strategic cooperation agreement with Halodoc, the largest telehealth platform in Indonesia to widen its product portfolio, including in-vitro diagnostics (IVD) technologies and integrated solutions.   

Gain a Competitive Edge with Our Indonesia In Vitro Diagnostics (IVD) Market Report

• Indonesia In Vitro Diagnostics (IVD) Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• The Indonesia In Vitro Diagnostics (IVD) Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.